๐Ÿ’Š๐Ÿ’‰ #everolimus SmPC for Certicanยฎ 0.25 mg tablets Certicanยฎ 0.75 mg tablets has been updated with changes to sections 3. Pharmaceutical form; 4.2 Posology; 4.5 Interaction with other medicinal products; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; Revised: 16 July 2024 ๐ŸŒ https://www.medicines.org.uk/emc/product/1920/smpc Change log: https://www.medicines.org.uk/emc/product/1920/smpc/history
Certican Tablets - Summary of Product Characteristics (SmPC) - (emc)

Certican Tablets - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus
SmPC for Everolimus Dr. Reddy's 10 mg Tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.4 Special warnings and precautions for use; 4.5 Interaction with other medicinal products and other forms of interaction; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 02/2024.
๐ŸŒ https://www.medicines.org.uk/emc/product/12240/smpc
Change log: https://www.medicines.org.uk/emc/product/12240/smpc/history
Everolimus 10 mg Tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus 10 mg Tablets - Summary of Product Characteristics (SmPC) by Dr. Reddy's Laboratories (UK) Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus
SmPC for Everolimus Dr. Reddy's 2.5 mg Tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.4 Special warnings and precautions for use; 4.5 Interaction with other medicinal products and other forms of interaction; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 02/2024.
๐ŸŒ https://www.medicines.org.uk/emc/product/12238/smpc
Change log: https://www.medicines.org.uk/emc/product/12238/smpc/history
Everolimus 2.5 mg Tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus 2.5 mg Tablets - Summary of Product Characteristics (SmPC) by Dr. Reddy's Laboratories (UK) Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus
SmPC for Everolimus Dr. Reddy's 5 mg Tablets has been updated with changes to sections 4.2 Posology and method of administration; 4.4 Special warnings and precautions for use; 4.5 Interaction with other medicinal products and other forms of interaction; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 02/2024.
๐ŸŒ https://www.medicines.org.uk/emc/product/12239/smpc
Change log: https://www.medicines.org.uk/emc/product/12239/smpc/history
Everolimus 5 mg Tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus 5 mg Tablets - Summary of Product Characteristics (SmPC) by Dr. Reddy's Laboratories (UK) Ltd

I'm now keeping an eye on: The SmPC for Everolimus Ethypharm 2.5 mg tablets

๐ŸญEthypharm UK Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus.

I will let you know if it changes.

๐ŸŒ https://www.medicines.org.uk/emc/product/14607/smpc

Everolimus Ethypharm 2.5 mg tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus Ethypharm 2.5 mg tablets - Summary of Product Characteristics (SmPC) by Ethypharm UK Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus
SmPC for Everolimus Ethypharm 5 mg tablets has been updated with changes to sections 6.3 Shelf life; 10. Date of revision of the text on 19/12/2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/13483/smpc
Change log: https://www.medicines.org.uk/emc/product/13483/smpc/history
Everolimus Ethypharm 5 mg tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus Ethypharm 5 mg tablets - Summary of Product Characteristics (SmPC) by Ethypharm UK Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus
SmPC for Everolimus Ethypharm 10 mg tablets has been updated with changes to sections 6.3 Shelf life; 10. Date of revision of the text on 19/12/2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/14608/smpc
Change log: https://www.medicines.org.uk/emc/product/14608/smpc/history
Everolimus Ethypharm 10 mg tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus Ethypharm 10 mg tablets - Summary of Product Characteristics (SmPC) by Ethypharm UK Ltd

World First: 13-Year-Old Child Cured of a Deadly Brain Cancer

When Lucas was diagnosed with a rare type of brain tumor at the age of six, there was no doubting the prognosis.

ScienceAlert

I'm now keeping an eye on: The SmPC for Certican Tablets

๐ŸญNovartis Pharmaceuticals UK Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus.

I will let you know if it changes.

๐ŸŒ https://www.medicines.org.uk/emc/product/1920/smpc

Certican Tablets - Summary of Product Characteristics (SmPC) - (emc)

Certican Tablets - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

๐Ÿ’Š๐Ÿ’‰ #everolimus
SmPC for Everolimus Sandoz 10 mg Tablets has been updated with changes to sections 9. Date of first authorisation/renewal of the authorisation; 10. Date of revision of the text on 02/08/2023.
๐ŸŒ https://www.medicines.org.uk/emc/product/13458/smpc
Change log: https://www.medicines.org.uk/emc/product/13458/smpc/history
Everolimus Sandoz 10 mg Tablets - Summary of Product Characteristics (SmPC) - (emc)

Everolimus Sandoz 10 mg Tablets - Summary of Product Characteristics (SmPC) by Sandoz Limited